Status:
COMPLETED
Identification of Gene Biomarkers in Aging Skin
Lead Sponsor:
Interleukin Genetics, Inc.
Conditions:
Hyperpigmentation
Skin Aging
Eligibility:
FEMALE
20-75 years
Brief Summary
This study is a blinded, prospective, single-center, clinical study conducted in Japanese female subjects between the ages of 20-75 years. This design uses skin biopsy samples from environmentally exp...
Detailed Description
The primary objective of the skin aging study is to investigate changes in gene expression patterns that occur during the aging process.
Eligibility Criteria
Inclusion
- Individuals who are willing to read and sign an informed consent form prior to participating in the study.
- Individuals who have a temperature of less than or equal to 100 degrees F at the time of biopsy collection.
- Individuals who had not applied any sunless tanning product on the arms within the past year.
- Individuals with no prior history of alcoholism (or who consume fewer than 2 to 3 alcoholic beverages per day).
- Individuals who have not consumed any anti-aging nutritional supplements (multivitamins and multiminerals are acceptable) or aspirin, NSAIDS, or other pain medication in the last 48 hours before biopsy.
Exclusion
- Male gender
- Individuals who did not fit the 'inclusion criteria' above.
Key Trial Info
Start Date :
August 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2009
Estimated Enrollment :
121 Patients enrolled
Trial Details
Trial ID
NCT00884936
Start Date
August 1 2008
End Date
April 1 2009
Last Update
March 31 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Thomas J. Stephens & Associates, Japan Research Center
Tokyo, Japan, 114-0002